These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37966357)

  • 1. Comment on 'Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics'.
    Toplu SA; Altunisik N
    Clin Exp Dermatol; 2024 Mar; 49(4):394. PubMed ID: 37966357
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics.
    Megna M; Potestio L; Battista T; Camela E; Genco L; Noto M; Fabbrocini G; Martora F
    Clin Exp Dermatol; 2022 Dec; 47(12):2310-2312. PubMed ID: 36052835
    [No Abstract]   [Full Text] [Related]  

  • 3. Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study.
    Kvist-Hansen A; Pérez-Alós L; Al-Sofi RF; Heftdal LD; Hamm SR; Møller DL; Pries-Heje MM; Fogh K; Hansen CB; Hasselbalch RB; Madsen JR; Armenteros JJA; Frikke-Schmidt R; Hilsted L; Sørensen E; Ostrowski SR; Bundgaard H; Nielsen SD; Iversen K; Zachariae C; Garred P; Skov L
    Br J Dermatol; 2023 Apr; 188(5):661-669. PubMed ID: 36703193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of psoriasis patients on biologics during COVID-19: a single centre experience.
    Burlando M; Carmisciano L; Cozzani E; Parodi A
    J Dermatolog Treat; 2022 Feb; 33(1):596. PubMed ID: 32406283
    [No Abstract]   [Full Text] [Related]  

  • 5. New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series.
    Gargiulo L; Ibba L; Vignoli CA; Piscazzi F; Cortese A; Fiorillo G; Toso F; Pavia G; Valenti M; Avagliano J; Narcisi A; Costanzo A
    J Dermatolog Treat; 2023 Dec; 34(1):2198050. PubMed ID: 36995221
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of COVID-19 infection on patients with psoriasis treated with biologics: an Italian experience.
    Ruggiero A; Martora F; Picone V; Potestio L; Camela E; Battista T; Fabbrocini G; Megna M
    Clin Exp Dermatol; 2022 Dec; 47(12):2280-2282. PubMed ID: 35867020
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the efficacy and safety of plaque psoriasis treatment by TNF-α and IL-17A inhibitor biologics in patients who received the inactivated SARS-CoV-2 vaccine.
    Ye S; Sun H; Xu Z; Xu B; Wu N; Wu J
    Immun Inflamm Dis; 2023 Jul; 11(7):e938. PubMed ID: 37506146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to: "Commentary on 'Role of phototherapy in the era of biologics'".
    Torres AE; Lyons AB; Hamzavi IH; Lim HW
    J Am Acad Dermatol; 2021 Feb; 84(2):e95-e96. PubMed ID: 32950547
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding views of patients on biologics for psoriasis amid the COVID-19 pandemic.
    Pandher K; Porter CL; Patel HS; Huang WW; Feldman SR
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e249-e251. PubMed ID: 33332687
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity 6 months after COVID-19 vaccination in patients with psoriasis treated with immunomodulatory drugs.
    Br J Dermatol; 2023 Apr; 188(5):e38. PubMed ID: 37078766
    [No Abstract]   [Full Text] [Related]  

  • 11. The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence.
    Zhang M; Bai X; Cao W; Ji J; Wang L; Yang Y; Yang H
    Front Immunol; 2021; 12():677957. PubMed ID: 34335579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of SARS-CoV-2 vaccines in psoriatic patients treated with biologics: A real life experience.
    Musumeci ML; Caruso G; Trecarichi AC; Micali G
    Dermatol Ther; 2022 Jan; 35(1):e15177. PubMed ID: 34699117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course.
    Yalici-Armagan B; Tabak GH; Dogan-Gunaydin S; Gulseren D; Akdogan N; Atakan N
    J Cosmet Dermatol; 2021 Oct; 20(10):3098-3102. PubMed ID: 34365714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of psoriasis patients during the COVID-19 pandemic.
    Chat VS; Uppal SK; Kearns DG; Wu JJ
    J Dermatolog Treat; 2022 Mar; 33(2):1166-1167. PubMed ID: 32568009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis.
    Gisondi P; Geat D; Bellinato F; Girolomoni G
    Expert Opin Biol Ther; 2022 Dec; 22(12):1521-1529. PubMed ID: 35930356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of plaque psoriasis by sequential therapy with two 'biologics': the 'hit and run' approach, a report of two cases.
    Barde C; Thielen AM; Kuenzli S; Saurat JH
    Br J Dermatol; 2006 Jul; 155(1):211-3. PubMed ID: 16792780
    [No Abstract]   [Full Text] [Related]  

  • 17. A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.
    Ghoreishi Amin N; Khosravi S; Atefi N; Seirafianpour F; Farhoodi S; Goodarzi A
    Immun Inflamm Dis; 2023 Nov; 11(11):e1063. PubMed ID: 38018599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience - Franche Comté, France.
    Gallais-Serezal I; Puzenat E; Moreau J; Dresco F; Pelletier F; Nardin C; Aubin F
    Eur J Dermatol; 2021 Feb; 31(1):101-103. PubMed ID: 33586651
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies.
    Carrascosa JM; van Doorn MB; Lahfa M; Nestle FO; Jullien D; Prinz JC
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1424-30. PubMed ID: 24841895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and psoriasis: biologic treatment and challenges.
    Ebrahimi A; Sayad B; Rahimi Z
    J Dermatolog Treat; 2022 Mar; 33(2):699-703. PubMed ID: 32598204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.